GENERA ISTRAŽIVANJA d.o.o.
Svetonedjeljska 2, 10000 KalinovicaAt Genera Research Ltd., we are on a mission to revolutionize bone healing. Based in Croatia, we are a clinical-stage biotechnology company dedicated to developing recombinant human Bone Morphogenetic Protein (BMP) based products for tissue regeneration and treating orthopedic, spinal, and dental conditions. Our innovative approach includes the production of recombinant human morphogenetic protein 6 (rhBMP6) and conducting clinical studies. With over 30 globally protected patents, we are proud to advance our patented innovation "OSTEOGROW" – a family of biological products designed for bone healing. Join us in our mission to make a difference in patients' lives worldwide.
Equal Employment Opportunity Commitment
Genera Research Ltd. provides equal employment opportunities for all individuals. Employment decisions are made without regard to age, race, creed, color, religion, sex, disability, pregnancy, medical condition, sexual orientation, gender identity or expression, ancestry, veteran status, national or ethnic origin, or any other status protected by applicable laws. We are committed to fostering a diverse and inclusive workplace.
Project Research and development of an advanced formulation for alveolar ridge augmentation – OSTEOproDENT
Funded by the European Regional Development Fund (State support for strategic innovation partnerships), the project aims to develop a formulation from concept (TRL 3) to a fully validated drug ready for regulatory submission (TRL 8) over three years: from January 13, 2025, to January 13, 2028. The applicant is Sartorius, with partners including Genera Research for manufacturing and clinical trials, Bekavac Dental Clinic for practical insights and protocol development, and the School of Medicine for preclinical and clinical trials.
